Health ❯ Healthcare ❯ Drug Development

Regulatory Affairs

FDA Approval Process FDA Approval Animal Testing Alternatives Clinical Trials FDA Designations FDA Applications RMAT Designation Biologics License Application FDA Processes Drug Discontinuation FDA Submissions EMA Approval

Xenon to Present Topline X-TOLE2 Phase 3 Results in Focal Onset Seizures at 8 A.M. ET Today

The webcast will deliver the first Phase 3 readout for azetukalner in focal onset seizures.

FDA Rejects Filing of Moderna’s mRNA Flu Vaccine Over Comparator Dispute

Athira Pharma Secures Exclusive Lasofoxifene Rights, Raises $90 Million to Advance Phase 3 Breast Cancer Program

DBV Peanut Allergy Patch Succeeds in Pivotal Phase 3, Setting Up 2026 FDA Filing

Teclistamab–Daratumumab Delivers Major Survival Gains in Relapsed Myeloma, Phase 3 Data Show

Nuvalent Reports 31% ORR in Pretreated, 86% in Untreated ALK+ NSCLC With Neladalkib

Sanofi to Acquire Blueprint Medicines for $9.1 Billion, Boosting Its Rare Immunology Pipeline

Mixed Phase 3 Outcomes Cloud Future of Regeneron and Sanofi’s COPD Candidate Itepekimab